Investors in Science

Axilium Holding was established in Gothenburg, Sweden in 2018. Empowered with significant investment experience in several fields, a wide professional network, and a strong desire to succeed, the two founders established an innovative investment company focusing on early stage Technology and Life Science companies based predominantly in Europe.

They invest in early-stage companies from seed to A-round and sometimes earlier, with initial investments typically ranging from 10-50 million SEK. Their evergreen fund structure allows them to prioritize long-term value over short-term gains. They focus on unique, scalable innovations that can have a meaningful societal impact, led by passionate founders capable of driving industry-changing ideas to fruition.

We create, accelerate and invest in deep-tech startups. Mission of Commercialization Reactor is to bring meaningful startups to the Global market and to provide a feasible opportunity for everyone – scientists, startup founders, investors and industrial corporations. We are an international platform for science commercialization

Tecnet equity is an Austrian venture capital fund investing in new technology enterprises as well as companies with innovative business ideas through venture capital. As an early-stage investor, tecnet plays an active part in the Austrian start-up landscape for many years. The support tecnet provides goes far beyond a financial investment. Withpersonal commitment, an international business network and many years of experience, tecnet support you in making your business successful.

QC·VENTURES is a Venture Capital investment platform of Q·ADVISERS that builds ad hoc investor syndicates around ideas and around a core team of experienced corporate finance professionals. QC invests in companies that have the potential for growth, disruption, and ambition to scale internationally.

Public VC, fostering the Start-Up Ecosystem in Rhineland-Palatinate; Germany. Looking for early stage ventures with strong innovative technical aproach, skilful founderteam and scaleable marketpotential. Investing equity or equity-like up to 500 k€ initially.

Hummingbird Ventures is a global early stage venture capital fund backing outlier founders. They are global seed investors, looking for outlier founders. Hummingbird believes groundbreaking companies are built by a rare breed of entrepreneur.

LRM is a venture capitalist providing smart money, giving companies the necessary oxygen for growth. Additionally, they manage three business campuses and offer opportunities for entrepreneurs seeking industrial estates. On the former mine sites be-MINE and Terhills, they are accomplishing impressive transformations.

Coinvest Capital invests in start-ups and companies undergoing business development and growth with groups of business angels.

Baltic Sandbox Ventures is a venture capital business that only invests in early-stage deep technology and life science solutions.

Novalis Biotech is an early-stage venture capital investor in life sciences. They welcome innovative concepts in healthcare and aim to support their development from the state of incorporation. Their investment focus is on “enabling technologies” in life sciences. They strongly believe in capital-light platform technology and close interaction with customers early in the life of the company. Focus areas include innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health.

Sciety was started in 2016 by a founding team with diverse backgrounds in physics, business, medicine and finance. Since our start, we have invested over 1 billion SEK in 25 companies, whereof 8 companies have been successfully acquired or listed on the stock exchange. We are based in Stockholm, but travel across the Nordics to meet with leading ventures and investors.